Article thumbnail
Location of Repository

SIVsm Tat, Rev, and Nef1: functional characteristics of r-GV internalization on isotypes, cytokines, and intracellular degradation

By Marinko Sremac and Elizabeth S Stuart
Topics: Research Article
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2916889
Provided by: PubMed Central

Suggested articles

Citations

  1. (2001). Antigen presentation using novel particulate organelles from halophilic archaea.
  2. (1997). Arora P: Genetic analysis of the gas vesicle cluster in haloarchaea.
  3. (1973). Ballou CE: Analysis of Halobacterium halobium gas vesicles.
  4. (2003). C: Prevention of disease induced by a partially heterologous AIDS virus in rhesus monkeys by using an adjuvanted multicomponent protein vaccine.
  5. (2008). Control of cytokine gene transcription
  6. (1996). Cytokines and the immune response. Biotherapy
  7. (2004). Dassarma S: Cassette-based presentation of SIV epitopes with recombinant gas vesicles from halophilic archaea.
  8. (1994). DD: Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.
  9. (1991). de Vries JE: Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.
  10. (1996). Development of Th 1- or Th 2-dominated immune responses: what about the polarizing signals?
  11. (1995). Emini EA, Conley AJ, Letvin NL: A vaccine-elicited, single viral epitope-specific cytotoxic T lymphocyte response does not protect against intravenous, cell-free simian immunodeficiency virus challenge.
  12. (2008). ES: Recombinant gas vesicles from Halobacterium sp. displaying SIV peptides demonstrate biotechnology potential as a pathogen peptide delivery vehicle.
  13. (1991). Evolving principles in immunopathology: interleukin 10 and its relationship to Epstein-Barr virus protein BCRF1. Springer Semin Immunopathol
  14. (2002). Fakan S: Rev inhibition strongly affects intracellular distribution of human immunodeficiency virus type 1 RNAs.
  15. (1996). Fauci AS: Cytokine regulation of HIV replication induced by dendritic cell-CD4-positive T cell interactions. AIDS Res Hum Retroviruses
  16. (1994). Fauci AS: Interleukin 10 blocks HIV replication in macrophages by inhibiting the autocrine loop of tumor necrosis factor alpha and interleukin 6 induction of virus. AIDS Res Hum Retroviruses
  17. (2000). Gallo RC: Vaccination with tat toxoid attenuates disease in simian/HIV-challenged macaques. Proc Natl Acad Sci USA
  18. (1994). Gas vesicles. Microbiol Rev
  19. (1990). Gendelman HE: Macrophages as susceptible targets for HIV infection, persistent viral reservoirs in tissue, and key immunoregulatory cells that control levels of virus replication and extent of disease. AIDS Res Hum Retroviruses
  20. (1993). GM: A TH1– > TH2 switch is a critical step in the etiology of HIV infection. Immunol Today
  21. (1989). Hayes PK: Gas vesicle proteins.
  22. (2001). Heeney JL: Rational development of prophylactic HIV vaccines based on structural and regulatory proteins. Vaccine
  23. (2002). HL: Critical role for Env as well as Gag-Pol in control of a simian-human immunodeficiency virus 89.6P challenge by a DNA prime/recombinant modified vaccinia virus Ankara vaccine.
  24. (1999). IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family.
  25. (2002). Immunoregulatory functions of interleukin 18 and its role in defense against bacterial pathogens.
  26. (2004). Interactions among human immunodeficiency virus (HIV)-1, interferon-gamma and receptor of activated NF-kappa B ligand (RANKL): implications for HIV pathogenesis. Clin Exp Immunol
  27. (1998). Intracellular trafficking and interactions of the HIV-1 Tat protein. Virology
  28. Macrophage deactivation by interleukin
  29. (1991). Med
  30. (2000). Minimization of chronic plasma viremia in rhesus macaques immunized with synthetic HIV-1 Tat peptides and infected with a chimeric simian/human immunodeficiency virus (SHIV33). Vaccine
  31. (1989). Mosmann TR: Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones.
  32. (2002). Outcome of simian-human immunodeficiency virus strain 89.6p challenge following vaccination of rhesus macaques with human immunodeficiency virus Tat protein.
  33. (1997). Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science
  34. (2008). Ravetch JV: Fc gamma receptors as regulators of immune responses. Nat Rev Immunol
  35. (1992). SL: Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation. Proc Natl Acad Sci USA
  36. (1991). Suntinanalert P: Halophiles in Thai Fish Sauce (Nam Pla). General and Applied Aspects of Halophilic
  37. (2010). Tat-vaccinated macaques do not control simian immunodeficiency virus SIVmac239 replication.
  38. (2000). Tatspecific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia.
  39. (1993). The rightward gas vesicle operon in Halobacterium plasmid pNRC100: identification of the gvpA and gvpC gene products by use of antibody probes and genetic analysis of the region downstream of gvpC.
  40. (1997). The Th1/Th2 paradigm. Immunol Today
  41. (2009). Thomsen AR: Co-ordinating innate and adaptive immunity to viral infection: mobility is the key. APMIS
  42. (1999). Vaccination with Rev and Tat against AIDS. Vaccine
  43. (1994). Yarchoan R: Interleukin-10 suppresses human immunodeficiency virus-1 replication in vitro in cells of the monocyte/macrophage lineage. Blood

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.